Investigators recently developed and validated an artificial intelligence–based model that can help clinicians predict which patients in the intensive care unit are most likely to develop acute kidney injury.
In an analysis of data from the Framingham Heart Study, albuminuria (a marker of kidney disease) was associated with signs of silent stroke, and patients with albuminuria had a higher risk of developing mild cognitive impairment or dementia.
A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.
The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.
An analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with ticagrelor–aspirin versus clopidogrel–aspirin. The analysis is published in Annals of Internal Medicine.
● The Congressional Kidney Caucus recognizes the 50th anniversary of the Medicare End-Stage Renal Disease (ESRD) Program.
● Kidney health leaders join the Congressional Kidney Caucus in calling for greater emphasis on intervening earlier and increasing disease awareness, increasing access to transplantation, and accelerating innovation in kidney health in the future of the ESRD Program.
New onset chronic kidney disease (CKD) in people with diabetes is highest among racial and ethnic minority groups compared with white persons, a UCLA-Providence study finds. The study, published as a letter to the editor in the New England Journal of Medicine, found that new onset CKD rates were higher by approximately 60%, 40%, 33%, and 25% in the Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations, respectively, compared to white persons with diabetes.
● Among individuals with varying levels of chronic kidney disease who were not on dialysis, the prevalence of individual symptoms ranged from 24% (chest pain) to 83% (fatigue), and 98% of participants reported at least one symptom.
● Patients categorized as having a “Worse symptom score and worsening trajectory” of symptoms had higher risks of later needing dialysis and of dying before dialysis initiation.
The American Society of Nephrology (ASN) will hold Kidney Week, the world’s premier kidney meeting, in Orlando, FL, November 3–6, 2022. The results of scientific studies and high-impact clinical trials that will advance kidney-related research and medical care will be presented in-person and online.
In 2019, two Canadian provinces passed deemed consent legislation, where adults are automatically presumed to consent to organ donation upon their death unless they registered to opt out.
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
Researchers at the Miller School are looking for solutions to the continued effects of alcohol use, its harmful impact, and treatment. Understanding the mechanisms of alcohol abuse has gained importance, especially after the COVID-19 pandemic. Higher alcohol consumption led to an increased burden of pancreatic diseases in society.
Today, patients utilizing their Medicare Hospice Benefits with end-stage kidney disease (ESKD) are forced to make the traumatic choice between continuing dialysis or enrolling in hospice.
The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.
Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.
In the procedure, the physician uses a handheld transducer placed on the skin to direct ultrasound waves towards the stone. The ultrasound can then be used to move and reposition the stones to promote their passage, a process called ultrasound propulsion, or the break up the stone, a technique called burst wave lithotripsy (BWL).
A new technique combining two types of focused ultrasound waves offers a promising approach for treatment of urinary stones located in the ureter, according to a feasibility study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
“We are excited to open our 18th hospital in the Hackensack Meridian Health network. This new LTACH will provide numerous benefits to our patients, their families and our community, which will lead to optimizing patient outcomes,” said Robert Garrett, chief executive officer, Hackensack Meridian Health.
First pediatric international conference on acute kidney injury (AKI) resulted in an expert consensus statement published in the journal JAMA Network Open. In this milestone publication, 46 global experts identify key issues in pediatric AKI and set a focused research agenda for the next five to 10 years.
Today, advocates of the American Society of Nephrology (ASN) and 21 other kidney health professional and patient organizations are meeting with their congressional delegations, calling on them to protect living donors and improve access to transplantation
Acute kidney injury is among the top causes of hospitalization during a heat wave. New research sheds light on why kidney injury increases during heat waves and why certain populations are at greater risk. The study was chosen as an APSselect article for September.
The National Cancer Institute (NCI) has renewed UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center Kidney Cancer Program (KCP) Specialized Program of Research Excellence (SPORE) award. First awarded in 2016, the KCP SPORE is focused on translating discoveries and innovation at UT Southwestern into advances in patient care.
Cálculos renais podem causar dores lancinantes e estão relacionados à doença renal crônica, osteoporose e doença cardiovascular. Pessoas que tiveram cálculo renal uma vez têm 30 por cento de chance de ter outra incidência dentro de cinco anos. Incluir alimentos ricos em cálcio e potássio pode prevenir cálculos renais recorrentes, conforme descoberto pelo estudo da Mayo Clinic.
مدينة روتشستر، ولاية مينيسوتا- قد تسبب حصوات الكلى ألمًا مبرحًا وترتبط بأمراض الكلى المزمنة وهشاشة العظام والمرض القلبي الوعائي. ومن يُصاب بحصوات الكلى مرةً لديه فرصة بنسبة 30% للإصابة بحصوة أخرى في غضون خمس سنوات. كما وجدت دراسة أجرتها مايو كلينك أن تناول الأطعمة الغنية بالكالسيوم والبوتاسيوم قد يمنع تكرار حصوات الكلى.
Los cálculos renales pueden causar un dolor insoportable y se los asocia con la enfermedad renal crónica, la osteoporosis y la enfermedad cardiovascular. Las personas que tuvieron un cálculo renal por primera vez tienen un 30 por ciento de probabilidades de presentar otro en un periodo de cinco años. Según un estudio de Mayo Clinic incluir alimentos con alto contenido de calcio y potasio puede prevenir la recurrencia de los cálculos renales.
New clinical equations that estimate individuals’ kidney function have eliminated an adjustment for Black race. This study examined the impact of using these new race-free equations on the accumulation of waiting time for kidney transplantation before a patient needs dialysis.
Washington, DC (September 16, 2022) —The American Society of Nephrology (ASN) is honored to announce its donation of $25,000 to the onePulse Foundation as a part of ASN’s pledge to bring its values to Florida. ASN encourages others to contribute to this campaign and support the Foundation’s mission to create and support a memorial that opens hearts, a museum that opens minds, educational programs that open eyes, and legacy scholarships that open doors.
Blocking the inhibition of PKD1 and PKD2 gene expression by deleting a binding site for microRNAs hindered the formation and growth of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD) models, UT Southwestern researchers reported. The findings, published in Nature Communications, suggest a strategy for gene therapy with the potential to arrest or cure ADPKD.
Researchers at Johns Hopkins Medicine report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy (DMD).
The five-year innovative pilot program offers financial support for trainees entering the field of nephrology, focusing on individuals historically underrepresented in medicine.
After a rare disease caused organ failure, UC San Diego Heath transplant teams performed a heart, liver and kidney transplant on a patient. The surgery is a first for UC San Diego Health and a first in the nation to use three organs from a donor after circulatory death.
UHN’s Ajmera Transplant Centre and The Centre for Living Organ Donation announce today the launch of a new campaign, Great Actions Leave a Mark, www.greatactions.ca. The campaign showcases through artistic photos and video, the stories and scars (the mark) from 39 living organ donors and transplant recipients across Canada.
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer Institute.
A series of upcoming studies will explore whether the grind of active-duty military life and veterans’ disproportionately high incidence of chronic illness could be tamed by lifestyle interventions designed to achieve a metabolic state of nutritional ketosis.
Combination therapies show encouraging results in several studies led by Dana-Farber Cancer Institute and presented for the first time at the European Society of Medical Oncology (ESMO) Congress 2022, Paris, France. The studies will be presented both in-person and online on September 9-13, 2022.
McKelvey Engineering, School of Medicine collaborate to develop hydrogel system that preserves the biochemistry and mechanical environments of cultured podocyte cells